Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Mammalian CX3C chemokine antibodies

Mammalian CX3C chemokine antibodies

US Patent 7585502 · Granted Sep 8, 2009

Estimated economic value: $139,526,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of treating focal segmental glomerulosclerosis2025
Compositions and methods for treating inflammatory bowel disease using CCR9 inhi2024
Methods of treating hidradenitis suppurativa2023
Reducing tumor burden by administering CCR1 antagonists in combination with PD-12023
Treatment of focal segmental glomerulosclerosis with CCR2 antagonists2022
Method of Treating Focal Segmental Glomerulosclerosis2022
Combination therapy using a chemokine receptor 2 (CCR2) antagonist and a PD-1/PD2022
Compositions and methods for treating inflammatory bowel disease using a combina2021
Compositions and methods for treating inflammatory bowel disease using a combina2021
Method of treating focal segmental glomerulosclerosis2021
Compositions and methods for treating inflammatory bowel disease using CCR9 inhi2020
Treatment of focal segmental glomerulosclerosis with CCR2 antagonists2020